- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.8: 3 residues within 4Å:- Chain B: N.700, Q.909, Q.1054
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.909
NAG-NAG-BMA.9: 4 residues within 4Å:- Chain B: D.779, N.784, S.786, Q.787
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 4 residues within 4Å:- Chain C: D.779, N.784, S.786, Q.787
No protein-ligand interaction detected (PLIP)- 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.17: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.692, G.1114
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.1057
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain A: N.319, T.321, K.567, T.568
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: Q.33, D.64, N.66
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: N.331, S.359, T.360
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain B: N.692
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.1057
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.1117
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: N.319, P.566, K.567
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain C: Q.33, N.66
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain C: N.110, K.111, E.132, F.158
- Ligands: NAG.30
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain C: N.130, F.158, N.159
- Ligands: NAG.29
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain B: R.450
- Chain C: S.106, T.107, N.228, T.230
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.590
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.692
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.1057
Ligand excluded by PLIPNAG.36: 6 residues within 4Å:- Chain C: N.120, S.121, N.123, V.125, Q.148, V.165
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain C: N.319, K.567, T.568, S.569
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Qiao, S. et al., Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1. J.Virol. (2024)
- Release Date
- 2024-07-17
- Peptides
- Spike glycoprotein,Fibritin: ABC
Processed angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Qiao, S. et al., Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1. J.Virol. (2024)
- Release Date
- 2024-07-17
- Peptides
- Spike glycoprotein,Fibritin: ABC
Processed angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
G